Hutch News

Hutch News

Stories tagged 'malaria'

Good News at Fred Hutch

Celebrating faculty and staff achievements

Nov. 30, 2017

The Parker Institute for Cancer Immunotherapy announced that Dr. Phil Greenberg, head of the Program in Immunology at the Hutch, has joined its team of more than 300 scientists from the academic, nonprofit, biotech and pharma sectors.

View story >


Getting malaria on purpose

Volunteers roll up their sleeves and get infected to test an experimental drug

April 25, 2016 | By Mary Engel / Fred Hutch News Service

Eight healthy adults ranging in age from 20 to 37 are taking part in a new study conducted by the Seattle Malaria Clinical Trials Center, run by Fred Hutchinson Cancer Research Center and the Center for Infectious Disease Research.

View story >


Malaria vaccine’s protectiveness depends on genetics of parasite

Genomics study, analysis help explain partial effectiveness, offer insights for improvement

Oct. 21, 2015 | By Mary Engel / Fred Hutch News Service

An experimental vaccine set to to win WHO approval as the first to even partially protect children against malaria works better against one strain of the disease-causing parasite than others.

View story >


Finding a better way to take a bite out of malaria’s power

Fred Hutch and collaborators launch new trials to infect – and quickly treat – volunteers to test experimental drugs

Sept. 10, 2014 | By Mary Engel / Fred Hutch News Service

Fred Hutch and collaborators launch new trials to infect – and quickly treat – volunteers to test experimental drugs.

View story >



GIVE NOW &
SAVE LIVES

Support our quest for cures

Story Archive


Publications

Hutch Magazine
Our quarterly magazine

Annual Report
Fiscal year highlights

Science Spotlight
Monthly review of Center-authored papers



Fred Hutch News

        Get updates via email.